CCL2 associated with CD38 expression during ex vivo expansion in human cord blood-derived hematopoietic stem cells.
To date, different experimental strategies have been developed for the ex vivo expansion of human hematopoietic stem cells (HSCs) for clinical applications. However, differences in the genomic function of expanded HSCs under different culture systems remain unclear. In this study, we compared the gene expression profiles of HSCs in ex vivo expanded serum (10% FBS, fetal bovine serum) and serum-free culture systems and analyzed the molecular functions of differentially expressed genes using microarray chips. We identified 839 differentially expressed genes between the two culture systems. These genes were enriched in the TNF -regulated inflammatory pathway in an FBS culture system. In addition, the mRNA expression of CCL2 (C-C motif chemokine ligand 2), TNF (tumor necrosis factor) and FOS (FBJ murine osteosarcoma viral oncogene homolog) was validated by RT-qPCR. Our data revealed that ex vivo expansion of HSCs using the FBS culture system induces an inflammatory response and high CD38 expression, indicating that this system might activate an inflammatory pathway and induce expression of the cancer marker CD38 during ex vivo expansion of HSCs. This study provides a transcriptional profile and new insights into the genomic functions of HSCs under different expanded cultures.
['Yao|Chao-Ling|CL|', 'Huang|Poyin|P|', 'Liu|Tsai-Chi|TC|', 'Lin|Yung-Kai|YK|', 'Chen|Ching-Yun|CY|', 'Lai|Yi-Ting|YT|', 'Chin|Tzu Yun|TY|', 'Tseng|Tsung-Yu|TY|', 'Hsu|Yi-Chiung|YC|']
CD38 hematopoietic stem cells microarray cord blood inflammation